Monitoring of measurable residual disease by next‐generation sequencing in patients with acute myeloid leukaemia.
Saved in:
| Title: | Monitoring of measurable residual disease by next‐generation sequencing in patients with acute myeloid leukaemia. |
|---|---|
| Authors: | Boudry, Augustin1,2 (AUTHOR), Goursaud, Laure3,4 (AUTHOR), Lebon, Delphine5,6 (AUTHOR), Dumezy, Florent1 (AUTHOR), Harrivel, Véronique7 (AUTHOR), Boue‐Raguet, Alexandre5 (AUTHOR), Joudinaud, Romane1,4 (AUTHOR), Marceau‐Renaut, Alice1,4 (AUTHOR), Geffroy, Sandrine1,4 (AUTHOR), Hauspie, Carine1 (AUTHOR), Brijs, Jan3,4 (AUTHOR), Fenwarth, Laurène1,4 (AUTHOR), Berthon, Céline3,4 (AUTHOR), Marolleau, Jean‐Pierre5,6 (AUTHOR), Figeac, Martin8 (AUTHOR), Preudhomme, Claude1,4 (AUTHOR), Duployez, Nicolas1,4 (AUTHOR) nicolas.duployez@chu‐lille.fr |
| Source: | British Journal of Haematology. Nov2025, Vol. 207 Issue 5, p1953-1961. 9p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
